Ignite Creation Date:
2024-05-05 @ 4:54 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00335270
Status:
COMPLETED
Last Update Posted:
2013-05-14
First Post:
2006-06-07
Brief Title:
A Randomized Prospective Study of the Efficacy Safety and Tolerability of Two Doses of GW433908Ritonavir Given With AbacavirLamivudine Fixed Dose Combination
Sponsor:
Duke University
Organization:
Duke University
Organization Data
Organization:
Duke University
Class:
OTHER
Study ID:
6692-05-12R1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Duke University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| GlaxoSmithKline | INDUSTRY |